PM&R
Volume 4, Issue 1 , Pages 4-10 , January 2012

Relationship Between Disability and Health-Related Quality of Life and Caregiver Burden in Patients With Upper Limb Poststroke Spasticity

Received 15 September 2010 ,Accepted 5 October 2011.

References 

  1. Lloyd-Jones D , Adams R , Carnethon M , et al.  Heart disease and stroke statistics—2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Circulation . 2009;119:480–486
  2. Sommerfeld DK , Eek EU , Svensson AK , Holmqvist LW , von Arbin MH . Spasticity after stroke: Its occurrence and association with motor impairments and activity limitations . Stroke . 2004;35:134–139
  3. Watkins CL , Leathley MJ , Gregson JM , Moore AP , Smith TL , Sharma AK . Prevalence of spasticity post stroke . Clin Rehabil . 2002;16:515–522
  4. Royal College of Physisicans . Spasticity in adults: Management using botulinum toxin . http://www rcplondon ac uk/pubs/contents/6988a14a-1179-4071-8f56-dc2a865f0a43 pdf 2009; Accessed August 5, 2010
  5. van Exel NJ , Scholte op Reimer WJ , Koopmanschap MA . Assessment of post-stroke quality of life in cost-effectiveness studies: The usefulness of the Barthel Index and the EuroQoL-5D . Qual Life Res . 2004;13:427–433
  6. Mayo NE , Wood-Dauphinee S , Cote R , Durcan L , Carlton J . Activity, participation, and quality of life 6 months poststroke . Arch Phys Med Rehabil . 2002;83:1035–1042
  7. Sturm JW , Donnan GA , Dewey HM , et al.  Quality of life after stroke: The North East Melbourne Stroke Incidence Study (NEMESIS) . Stroke . 2004;35:2340–2345
  8. Elovic EP , Brashear A , Kaelin D , et al.  Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients . Arch Phys Med Rehabil . 2008;89:799–806
  9. Caty GD , Detrembleur C , Bleyenheuft C , Deltombe T , Lejeune TM . Effect of upper limb botulinum toxin injections on impairment, activity, participation, and quality of life among stroke patients . Stroke . 2009;40:2589–2591
  10. Dolan P . Modeling valuations for EuroQol health states . Med Care . 1997;35:1095–1108
  11. van SA , de Haan RJ , Limburg M , Schuling J , Bossuyt PM , van den Bos GA . A stroke-adapted 30-item version of the Sickness Impact Profile to assess quality of life (SA-SIP30) . Stroke . 1997;28:2155–2161
  12. Niemi ML , Laaksonen R , Kotila M , Waltimo O . Quality of life 4 years after stroke . Stroke . 1988;19:1101–1107
  13. King RB . Quality of life after stroke . Stroke . 1996;27:1467–1472
  14. Buck D , Jacoby A , Massey A , Ford G . Evaluation of measures used to assess quality of life after stroke . Stroke . 2000;31:2004–2010
  15. Food and Drug Administration . Guidance for industry, patient-reported outcome measures: Use in medical product development to support labeling claims . http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf Accessed April, 1, 2011
  16. Brashear A , Zafonte R , Corcoran M , et al.  Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity . Arch Phys Med Rehabil . 2002;83:1349–1354
  17. EuroQol Group . EQ-5D User Guide: basic information on how to use EQ-5D . http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/User_Guide_v2_March_2009.pdf Accessed October 21, 2011
  18. Shaw JW , Johnson JA , Coons SJ . US valuation of the EQ-5D health states: Development and testing of the D1 valuation model . Med Care . 2005;43:203–220
  19. Xie J , Wu EQ , Zheng ZJ , Sullivan PW , Zhan L , Labarthe DR . Patient-reported health status in coronary heart disease in the United States: Age, sex, racial, and ethnic differences . Circulation . 2008;118:491–497
  20. Pickard AS , Neary MP , Cella D . Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer . Health Qual Life Outcomes . 2007;5:70
  21. Shikiar R , Willian MK , Okun MM , Thompson CS , Revicki DA . The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: Results of a phase II study . Health Qual Life Outcomes . 2006;4:71
  22. Post PN , Stiggelbout AM , Wakker PP . The utility of health states after stroke: A systematic review of the literature . Stroke . 2001;32:1425–1429
  23. Sullivan PW , Lawrence WF , Ghushchyan V . A national catalog of preference-based scores for chronic conditions in the United States . Med Care . 2005;43:736–749

 This CME activity is designated for 1.0 AMA PRA Category 1 Credit™ and can be completed online at me.aapmr.org. Log on to www.me.aapmr.org, go to Lifelong Learning (CME) and select Journal-based CME from the drop down menu. This activity is FREE to AAPM&R members and $25 for non-members.

 Peer reviewers and all others who control content have no relevant financial relationships to disclose.

 Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org

PII: S1934-1482(11)01285-8

doi: 10.1016/j.pmrj.2011.10.001

PM&R
Volume 4, Issue 1 , Pages 4-10 , January 2012

Article Tools